Suppr超能文献

术前 De Ritis 比值在上尿路尿路上皮癌行肾输尿管切除术治疗中的预后作用。

Prognostic role of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with nephroureterectomy.

机构信息

Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.

Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Medical University of Hamburg, Hamburg, Germany.

出版信息

Urol Oncol. 2020 Jun;38(6):601.e17-601.e24. doi: 10.1016/j.urolonc.2020.02.008. Epub 2020 Feb 29.

Abstract

PURPOSE

To validate the predictive and prognostic role of the De Ritis ratio in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy in a large multi-institutional cohort.

MATERIALS AND METHODS

The preoperative De Ritis ratio was assessed in a multi-institutional cohort of 2,492 patients. An altered De Ritis ratio was defined as a ratio >1.35. Logistic regression analyses were performed to assess the association of the De Ritis ratio with advanced disease. The association of the De Ritis ratio with survival outcomes was evaluated using Cox proportional hazards regression models.

RESULTS

An altered De Ritis ratio was observed in 985 (41.5%) patients; it was associated with a more advanced pathological features. In a preoperative model, the De Ritis ratio was an independent predictive factor for the presence of lymph node metastasis and muscle-invasive and nonorgan-confined disease (P < 0.05). Compared to patients with a normal De Ritis ratio, those with an altered De Ritis ratio had worse recurrence free (P <0.0001), cancer specific (P = 0.0003), and overall survival (P = 0.0014) in the Kaplan-Meier analyses. In the multivariable analyses that was adjusted for the effects of standard clinicopathologic features, the De Ritis ratio did not retain its independent prognostic value.

CONCLUSIONS

In UTUC, the preoperative De Ritis ratio is associated with adverse clinicopathologic features and independently predicts features of biologically and clinically aggressive UTUC. Therefore, it might be useful to incorporate the De Ritis ratio into prognostic tools in selecting appropriate treatment strategies.

摘要

目的

在一个大型多机构队列中,验证 De Ritis 比值在上尿路尿路上皮癌(UTUC)患者接受根治性肾输尿管切除术治疗中的预测和预后作用。

材料与方法

在一个多机构队列中,评估了 2492 例患者的术前 De Ritis 比值。定义异常 De Ritis 比值为比值>1.35。采用逻辑回归分析评估 De Ritis 比值与晚期疾病的相关性。采用Cox 比例风险回归模型评估 De Ritis 比值与生存结果的相关性。

结果

985 例(41.5%)患者观察到异常 De Ritis 比值;它与更晚期的病理特征相关。在术前模型中,De Ritis 比值是淋巴结转移和肌肉浸润性及非器官局限性疾病存在的独立预测因素(P<0.05)。与 De Ritis 比值正常的患者相比,比值异常的患者在无复发生存(P<0.0001)、癌症特异性生存(P=0.0003)和总生存(P=0.0014)方面的 Kaplan-Meier 分析结果更差。在调整了标准临床病理特征影响的多变量分析中,De Ritis 比值并未保留其独立的预后价值。

结论

在 UTUC 中,术前 De Ritis 比值与不良临床病理特征相关,并且独立预测具有生物学和临床侵袭性的 UTUC 特征。因此,将 De Ritis 比值纳入预后工具中选择适当的治疗策略可能是有用的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验